XCUR
Exicure (XCUR)
$61
About Exicure (XCUR)
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.
Details
Daily high
$4.70
Daily low
$4.46
Price at open
$4.46
52 Week High
$14.73
52 Week Low
$3.10
Market cap
28.5M
Dividend yield
0.00%
Volume
14,366
Avg. volume
24,508
P/E ratio
-2.97
Exicure News
Details
Daily high
$4.70
Daily low
$4.46
Price at open
$4.46
52 Week High
$14.73
52 Week Low
$3.10
Market cap
28.5M
Dividend yield
0.00%
Volume
14,366
Avg. volume
24,508
P/E ratio
-2.97